This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleming, P.
Right arrow Articles by Farrell, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleming, P.
Right arrow Articles by Farrell, H.

 Previous Article  |  Next Article 

Journal of Virology, August 1999, p. 6800-6809, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

The Murine Cytomegalovirus Chemokine Homolog, m131/129, Is a Determinant of Viral Pathogenicity

Peter Fleming,1 Nicholas Davis-Poynter,2 Mariapia Degli-Esposti,1 Eloise Densley,1 John Papadimitriou,3 Geoffrey Shellam,1 and Helen Farrell2,*

Departments of Microbiology1 and Pathology,3 University of Western Australia, Nedlands, Western Australia 6907, Australia, and Centre for Preventive Medicine, Animal Health Trust, Newmarket CB8 7UU, United Kingdom2

Received 10 February 1999/Accepted 15 April 1999

Chemokines are important mediators of the early inflammatory response to infection and modify a wide range of host immune responses. Functional homologs of cellular chemokines have been identified in a number of herpesviruses, suggesting that the subversion of the host chemokine response contributes to the pathogenesis of these viruses. Transcriptional and reverse transcription-PCR analyses demonstrated that the murine cytomegalovirus (MCMV) chemokine homolog, m131, was spliced at the 3' end to the adjacent downstream open reading frame, m129, resulting in a predicted product of 31 kDa, which is significantly larger than most known chemokines. The in vivo impact of m131/129 was investigated by comparing the replication of MCMV mutants having m131/129 deleted (Delta m131/129) with that of wild-type (wt) MCMV. Our studies demonstrate that both wt and Delta m131/129 viruses replicated to equivalent levels during the first 2 to 3 days following in vivo infection. However, histological studies demonstrated that the early inflammatory response elicited by Delta m131/129 was reduced compared with that of wt MCMV. Furthermore, the Delta m131/129 mutants failed to establish a high-titer infection in the salivary glands. These results suggest that m131/129 possesses proinflammatory properties in vivo and is important for the dissemination of MCMV to or infection of the salivary gland. Notably, the Delta m131/129 mutants were cleared more rapidly from the spleen and liver during acute infection compared with wt MCMV. The accelerated clearance of the mutants was dependent on NK cells and cells of the CD4+ CD8+ phenotype. These data suggest that m131/129 may also contribute to virus mechanisms of immune system evasion during early infection, possibly through the interference of NK cells and T cells.


* Corresponding author. Mailing address: Centre for Preventive Medicine, Animal Health Trust, Lanwades Park, Kentford, Newmarket, Suffolk CB8 7UU, United Kingdom. Phone: 44-1638-750659. Fax: 44-1638-750794. E-mail: helen.farrell{at}aht.org.uk.


Journal of Virology, August 1999, p. 6800-6809, Vol. 73, No. 8
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Cardin, R. D., Schaefer, G. C., Allen, J. R., Davis-Poynter, N. J., Farrell, H. E. (2009). The M33 Chemokine Receptor Homolog of Murine Cytomegalovirus Exhibits a Differential Tissue-Specific Role during In Vivo Replication and Latency. J. Virol. 83: 7590-7601 [Abstract] [Full Text]  
  • Dewin, D. R., Catusse, J., Gompels, U. A. (2006). Identification and Characterization of U83A Viral Chemokine, a Broad and Potent {beta}-Chemokine Agonist for Human CCRs with Unique Selectivity and Inhibition by Spliced Isoform. J. Immunol. 176: 544-556 [Abstract] [Full Text]  
  • Noda, S., Aguirre, S. A., Bitmansour, A., Brown, J. M., Sparer, T. E., Huang, J., Mocarski, E. S. (2006). Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107: 30-38 [Abstract] [Full Text]  
  • Hahn, G., Revello, M. G., Patrone, M., Percivalle, E., Campanini, G., Sarasini, A., Wagner, M., Gallina, A., Milanesi, G., Koszinowski, U., Baldanti, F., Gerna, G. (2004). Human Cytomegalovirus UL131-128 Genes Are Indispensable for Virus Growth in Endothelial Cells and Virus Transfer to Leukocytes. J. Virol. 78: 10023-10033 [Abstract] [Full Text]  
  • Kanamori, M., Watanabe, S., Honma, R., Kuroda, M., Imai, S., Takada, K., Yamamoto, N., Nishiyama, Y., Kawaguchi, Y. (2004). Epstein-Barr Virus Nuclear Antigen Leader Protein Induces Expression of Thymus- and Activation-Regulated Chemokine in B Cells. J. Virol. 78: 3984-3993 [Abstract] [Full Text]  
  • van der Strate, B. W. A., Hillebrands, J. L., Lycklama a Nijeholt, S. S., Beljaars, L., Bruggeman, C. A., van Luyn, M. J. A., Rozing, J., The, T. H., Meijer, D. K. F., Molema, G., Harmsen, M. C. (2003). Dissemination of Rat Cytomegalovirus through Infected Granulocytes and Monocytes In Vitro and In Vivo. J. Virol. 77: 11274-11278 [Abstract] [Full Text]  
  • Melchjorsen, J., Sorensen, L. N., Paludan, S. R. (2003). Expression and function of chemokines during viral infections: from molecular mechanisms to in vivo function. J. Leukoc. Biol. 74: 331-343 [Abstract] [Full Text]  
  • Akter, P., Cunningham, C., McSharry, B. P., Dolan, A., Addison, C., Dargan, D. J., Hassan-Walker, A. F., Emery, V. C., Griffiths, P. D., Wilkinson, G. W. G., Davison, A. J. (2003). Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84: 1117-1122 [Abstract] [Full Text]  
  • Zhu, J., Chen, J., Hai, R., Tong, T., Xiao, J., Zhan, X., Lu, S., Liu, F. (2003). In Vitro and In Vivo Characterization of a Murine Cytomegalovirus with a Mutation at Open Reading Frame m166. J. Virol. 77: 2882-2891 [Abstract] [Full Text]  
  • Oliveira, S. A., Park, S.-H., Lee, P., Bendelac, A., Shenk, T. E. (2002). Murine Cytomegalovirus m02 Gene Family Protects against Natural Killer Cell-Mediated Immune Surveillance. J. Virol. 76: 885-894 [Abstract] [Full Text]  
  • Liu, C., Okruzhnov, Y., Li, H., Nicholas, J. (2001). Human Herpesvirus 8 (HHV-8)-Encoded Cytokines Induce Expression of and Autocrine Signaling by Vascular Endothelial Growth Factor (VEGF) in HHV-8-Infected Primary-Effusion Lymphoma Cell Lines and Mediate VEGF-Independent Antiapoptotic Effects. J. Virol. 75: 10933-10940 [Abstract] [Full Text]  
  • Saederup, N., Aguirre, S. A., Sparer, T. E., Bouley, D. M., Mocarski, E. S. (2001). Murine Cytomegalovirus CC Chemokine Homolog MCK-2 (m131-129) Is a Determinant of Dissemination That Increases Inflammation at Initial Sites of Infection. J. Virol. 75: 9966-9976 [Abstract] [Full Text]  
  • Chensue, S. W. (2001). Molecular Machinations: Chemokine Signals in Host-Pathogen Interactions. Clin. Microbiol. Rev. 14: 821-835 [Abstract] [Full Text]  
  • Gardner, J. D., Tscharke, D. C., Reading, P. C., Smith, G. L. (2001). Vaccinia virus semaphorin A39R is a 50-55 kDa secreted glycoprotein that affects the outcome of infection in a murine intradermal model. J. Gen. Virol. 82: 2083-2093 [Abstract] [Full Text]  
  • Lee, M., Xiao, J., Haghjoo, E., Zhan, X., Abenes, G., Tuong, T., Dunn, W., Liu, F. (2000). Murine Cytomegalovirus Containing a Mutation at Open Reading Frame M37 Is Severely Attenuated in Growth and Virulence In Vivo. J. Virol. 74: 11099-11107 [Abstract] [Full Text]  
  • Nicholas, J (2000). Evolutionary aspects of oncogenic herpesviruses. Mol. Pathol. 53: 222-237 [Abstract] [Full Text]  
  • Vink, C., Beuken, E., Bruggeman, C. A. (2000). Complete DNA Sequence of the Rat Cytomegalovirus Genome. J. Virol. 74: 7656-7665 [Abstract] [Full Text]  
  • Murphy, P. M., Baggiolini, M., Charo, I. F., Hebert, C. A., Horuk, R., Matsushima, K., Miller, L. H., Oppenheim, J. J., Power, C. A. (2000). International Union of Pharmacology. XXII. Nomenclature for Chemokine Receptors. Pharmacol. Rev. 52: 145-176 [Abstract] [Full Text]  
  • Burns, J. M., Dairaghi, D. J., Deitz, M., Tsang, M., Schall, T. J. (2002). Comprehensive Mapping of Poxvirus vCCI Chemokine-binding Protein. EXPANDED RANGE OF LIGAND INTERACTIONS AND UNUSUAL DISSOCIATION KINETICS. J. Biol. Chem. 277: 2785-2789 [Abstract] [Full Text]